# A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes

> **NCT05478252** · PHASE3 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 388 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Semaglutide J
- **DRUG:** Semaglutide B

## Key facts

- **NCT ID:** NCT05478252
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-03
- **Primary completion:** 2023-08-09
- **Final completion:** 2023-09-18
- **Target enrollment:** 388 (ACTUAL)
- **Last updated:** 2025-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05478252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05478252, "A Research Study to Compare Two Semaglutide Medicines in People With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05478252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*